GLP-1 Weight Loss in Modesto, CA: A 36.2% Obesity Rate, an Eliminated Medi-Cal Benefit, and a Local Market That Rarely Publishes a Price
Modesto's city-vs-state obesity gap, California's January 2026 elimination of Medi-Cal GLP-1 weight-loss coverage, three local price structures, and a facility-level primary-care shortage.
Modesto's adult obesity crude prevalence is 36.2% (CDC PLACES, BRFSS 2023) 1 against California's statewide 27.7% (BRFSS 2023) 2, a gap of 8.5 percentage points. This is a city-to-state comparison by necessity: CDC PLACES publishes no separate Stanislaus County row alongside the city and state figures in this release.
Modesto is a city of 219,215 inside a 553,990-person metro, with a median household income of $79,891 and 4.7% uninsured 34. The insurance rate is unusually strong. What that coverage now excludes is the point.
No active geographic Primary Care HPSA currently covers Modesto's urban core: HRSA's current Primary Care file lists the historical "West Modesto" and "Ceres/Modesto South Central (MSSA 215C)" designations as WITHDRAWN (pulled 8/28/2026; source file last updated 8/27/2026). What IS currently designated in Stanislaus County: a county-wide Mental Health Low-Income Population HPSA (score 16, ~182,740 residents); a facility-based HPSA at the County of Stanislaus FQHC Look-Alike carrying a Modesto address across all three disciplines (Primary Care score 13/population 279,758; Mental Health score 16/population 472,123; Dental Health score 15/population 472,123); and additional geographic/population Primary Care HPSAs confined to outlying towns -- Oakdale/Riverbank (Medicaid-Eligible Population, score 13) and Hughson (Low-Income Migrant Farmworker Population, score 12) -- plus Rural Health Clinic facility HPSAs in Patterson and Newman. Net read: Stanislaus County's HRSA shortage footprint sits in behavioral health, one FQHC-look-alike facility, and the rural periphery -- not a citywide primary-care gap inside Modesto itself. (HPSA designations are a snapshot as of the file's stated update date and can change.)789
Specialist access
The CMS NPI Registry (pulled 8/28/2026) lists approximately 14 individual providers carrying an "Endocrinology, Diabetes & Metabolism" taxonomy with at least one practice location in Modesto -- a modest but real specialist bench for a metro of roughly 554,000, not a desert. (This is a raw NPI Registry match count, not independently verified for active-practice status or whether each provider actually prescribes GLP-1s.) That bench sits alongside the single facility-based Primary Care HPSA in the county -- the County of Stanislaus FQHC Look-Alike, Modesto address -- which signals real constraint on primary-care capacity for the county's low-income and Medicaid-dependent residents: the group most likely to need a referral into endocrinology or medical weight management in the first place. Telehealth removes that referral step entirely.10
Medicaid coverage note
Medi-Cal does not cover GLP-1 drugs for weight loss at all as of January 1, 2026 -- California's enacted 2025-26 state budget eliminated this coverage outright (estimated $85 million in General Fund savings in 2025-26, growing to $790 million by 2028-29), rather than merely restricting it with prior authorization or step therapy. Verbatim from the state's own enacted budget: "Specialty Drug Coverage for Weight Loss -- Elimination of coverage for Glucagon-Like Peptide-1 (GLP-1) drugs for weight loss effective January 1, 2026." KFF's Medicaid GLP-1 coverage tracker (published Jan 16, 2026) corroborates this, listing California among four states -- with New Hampshire, Pennsylvania, and South Carolina -- that "have eliminated coverage of GLP-1s for obesity treatment" since an October 2025 survey. Compounded (non-FDA-approved) semaglutide/tirzepatide of the kind Modesto's local med spas dispense was never a Medi-Cal-billable pharmacy benefit and remains untouched by (still excluded under) this change. Astra itself operates as a cash-pay telehealth service and does not bill Medicaid or insurance regardless of a patient's coverage status.1617
Medi-Cal eliminated GLP-1 weight-loss coverage on January 1, 2026
This was an elimination, not a new prior-authorization hurdle. California's enacted 2025-26 state budget removed the benefit outright, its own line item reading "Specialty Drug Coverage for Weight Loss -- Elimination of coverage for Glucagon-Like Peptide-1 (GLP-1) drugs for weight loss effective January 1, 2026," with an estimated $85 million in General Fund savings in 2025-26 growing to $790 million by 2028-29 16.
KFF's Medicaid GLP-1 coverage tracker, published Jan 16, 2026, corroborates it, listing California among four states that have eliminated GLP-1 obesity coverage since an October 2025 survey 17. Compounded semaglutide and tirzepatide, the kind Modesto's med spas dispense, were never a Medi-Cal-billable pharmacy benefit and remain excluded. Astra is cash-pay telehealth and does not bill Medicaid or insurance for any patient.
What GLP-1 care costs in Modesto today
Serene Aesthetics & MedSpa, at 2401 Coffee Rd, publishes a dose-escalating compounded-semaglutide schedule on its own site: Month 1 (0.25mg) $600/mo, Month 2 (0.50mg) $650/mo, Month 3 (1.0mg) $700/mo, Month 4 (1.7mg) $750/mo, and Month 5 maintenance (2.4mg) $800/mo, each tier $50/mo higher with a lipotropic shot add-on, for $650 to $850/mo all-in, plus $120 lab work initially and $120 again after six months. No tirzepatide price is published anywhere on the site. Checked 2026-08-28 12.
Dynamic Functional Medicine, A Nursing PC, at 2401 E Orangeburg Ave, splits the bill: a 3-tier monthly membership for dose management that excludes medication (Foundation $149/mo, Core $199/mo, Root Cause $279/mo), with medication billed separately and banded by dose at $200-$300/mo for early doses, $300-$450/mo mid-range, and $450-$700+/mo at higher doses. All-in that is roughly $349 to $979+/mo. Its materials use generic "GLP-1" language without naming semaglutide or tirzepatide separately. Checked 2026-08-28 1314.
Ego Beauty and Wellness Defined, at 1300 Mable Ave Ste C, lists both semaglutide and tirzepatide under Medical Weight Loss and publishes no price at all, consult-only. Checked 2026-08-28 15. It is representative: of 6 Modesto-address weight-loss and med-spa businesses found via BBB, 3 have parked or expired domains and 1 more errored out, leaving 2 of 6 with genuinely live published GLP-1 pricing 11.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 billed annually, identical in every city Astra serves.
Fourteen endocrinology providers, one facility-level bottleneck
The CMS NPI Registry, pulled 8/28/2026, lists approximately 14 individual providers carrying an Endocrinology, Diabetes & Metabolism taxonomy with at least one practice location in Modesto 10, a modest but real specialist bench for a metro of roughly 554,000, not a desert. That is a raw registry match count, not a verification of active practice or GLP-1 prescribing.
No active geographic Primary Care HPSA covers Modesto's urban core: the historical "West Modesto" and "Ceres/Modesto South Central (MSSA 215C)" designations are listed WITHDRAWN in HRSA's current file, pulled 8/28/2026 7. What is designated in Stanislaus County is a county-wide Mental Health Low-Income Population HPSA (score 16, roughly 182,740 residents) 8, and a facility-based HPSA at the County of Stanislaus FQHC Look-Alike carrying a Modesto address across all three disciplines: Primary Care score 13 (population 279,758), Mental Health score 16 and Dental Health score 15 (population 472,123 each) 789. Remaining geographic primary-care designations sit in the rural periphery, in Oakdale/Riverbank, Hughson, Patterson, and Newman.
So the constraint is upstream of endocrinology: the county's low-income and Medicaid-dependent residents, the group most likely to need the referral, hit the primary-care bottleneck first. Telehealth removes that referral step entirely. See the California GLP-1 overview for statewide context.
Astra treats patients in California through state-licensed physicians.
Local options
Serene Aesthetics & MedSpa (2401 Coffee Rd, Modesto, CA 95355) — Publishes a dose-escalating compounded-semaglutide protocol directly on its own site: Month 1 (0.25mg) $600/mo, Month 2 (0.50mg) $650/mo, Month 3 (1.0mg) $700/mo, Month 4 (1.7mg) $750/mo, Month 5/maintenance (2.4mg) $800/mo -- each tier +$50/mo with a "lipotropic" shot add-on ($650-$850/mo all-in). Plus required lab work: $120 initial, $120 again after 6 months. No tirzepatide price is published anywhere on the site -- confirmed against the homepage and the /tirzepatide URL, which 404s. https://sereneaestheticsandmedspa.com/semaglutide(checked 2026-08-28)
Dynamic Functional Medicine, A Nursing PC (2401 E Orangeburg Ave, Modesto, CA 95355) — Publishes a 3-tier monthly membership for GLP-1 dose management that EXCLUDES medication: Foundation $149/mo (check-in, dose management + prescription oversight, secure messaging, refill coordination), Core $199/mo ("Most Popular" -- adds priority messaging, monthly progress review, personalized nutrition coaching, ongoing dose titration), Root Cause $279/mo (adds extended visits, functional-medicine hormone/gut/metabolic protocols, priority scheduling). Medication is billed separately, banded by dose: Early doses $200-$300/mo, Mid-range $300-$450/mo, Higher doses $450-$700+/mo. All-in monthly cost therefore ranges roughly $349 to $979+ depending on tier and dose reached. Uses generic "GLP-1" language throughout -- semaglutide and tirzepatide are not named separately. Every figure verified directly against the practice's own published pricing graphic (the numbers live in an image, not page text). https://irp.cdn-website.com/e3b69478/files/uploaded/pricing+glp1-5373c97f.png(checked 2026-08-28)
Ego Beauty and Wellness Defined (1300 Mable Ave Ste C, Modesto, CA 95355) — Lists both semaglutide and tirzepatide under its "Medical Weight Loss" service, but publishes no price, dose schedule, or package cost anywhere on the site (consult-only). Representative of the broader local pattern: of 6 Modesto-address weight-loss/med-spa businesses identified via BBB's directory, 3 have parked or expired domains with no live site at all (Bee Skinny Inc.; Rejuvenation Med & Health Spa, d/b/a modestomedspa.com; Paradigm Health & Med Spa / Aesthetic Wellness & Ketamine Infusion Clinic, both at paradigminfusions.com) and 1 more (Access Wellness Healthcare) returned a server error on the day checked -- leaving only 2 of 6 with genuinely live, published GLP-1 pricing. Treat this as a lower bound on local providers, not an exhaustive census (Yelp, Yellow Pages, Google, DuckDuckGo, Ecosia, and Startpage all blocked or JS-gated automated access). https://egodefined.com/medical-weight-loss-doctor(checked 2026-08-28)
Frequently asked questions
How much does semaglutide or tirzepatide cost from a local Modesto provider?
It depends heavily on which of two Modesto providers with published pricing you use -- four other med-spa/weight-loss businesses found in local directories no longer have a working site. Serene Aesthetics & MedSpa publishes a compounded-semaglutide-only schedule that climbs from $600/month at the starting dose to $800/month at maintenance (plus $120 lab work, twice), with no tirzepatide price published anywhere on its site. Dynamic Functional Medicine charges a separate monthly membership ($149-$279) plus dose-banded medication ($200-$700+/month), for an all-in range of roughly $349-$979+/month depending on tier and dose -- using generic "GLP-1" language rather than naming a specific drug. (Checked 2026-08-28.)
Is Astra cheaper in Modesto?
Yes, in most cases -- and it's the only clearly priced option that doesn't require a phone call. Astra charges a flat $68/month for semaglutide and $118/month for tirzepatide on a 12-month plan ($816/$1,416 billed annually), the same price in Modesto as everywhere else Astra operates. Serene Aesthetics's compounded-semaglutide pricing ($600-$800/month) and Dynamic Functional Medicine's all-in cost ($349-$979+/month) both exceed Astra's price once a patient reaches a typical maintenance dose -- and neither publishes a tirzepatide price at all, so Modesto residents specifically wanting tirzepatide have no local, price-transparent option to compare against.
Is Modesto's obesity rate higher than the California average?
Yes. Modesto's adult obesity crude prevalence is 36.2% (CDC PLACES, BRFSS 2023 data) versus California's statewide rate of 27.7% (BRFSS 2023) -- a gap of 8.5 percentage points. CDC PLACES doesn't publish a separate Stanislaus County row alongside its city and state figures, so city-to-state is the cleanest comparison available.
Does Medi-Cal cover GLP-1 weight-loss drugs for Modesto residents?
No -- as of January 1, 2026, it does not. California's enacted 2025-26 state budget eliminated Medi-Cal coverage of GLP-1 drugs for weight loss entirely (an estimated $85 million in 2025-26 savings, growing to $790 million by 2028-29), rather than just adding prior-authorization rules. Compounded semaglutide and tirzepatide -- what Modesto's local med spas dispense -- were never covered by Medi-Cal to begin with. Astra is a cash-pay telehealth service and doesn't bill Medicaid or insurance for any patient, regardless of coverage status.
Is there a shortage of endocrinologists or weight-loss specialists in Modesto?
Not by raw numbers -- the CMS NPI Registry lists about 14 providers with an Endocrinology, Diabetes & Metabolism taxonomy practicing in Modesto, a reasonable bench for a metro of roughly 554,000. The tighter constraint sits upstream: HRSA designates a facility-based Primary Care shortage at the county's FQHC Look-Alike site with a Modesto address, meaning the lowest-income and Medicaid-dependent residents most likely to need a referral into specialty weight-loss care often hit a primary-care bottleneck first. Telehealth skips that referral step entirely.